Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer targets in the Ras pathway.

P Rodriguez-Viciana1, O Tetsu, K Oda

  • 1Cancer Research Institute, University of California San Francisco Comprehensive Cancer Center, 94115, USA.

Cold Spring Harbor Symposia on Quantitative Biology
|July 28, 2006
PubMed
Summary

Ras proteins are key drivers in human cancers, with mutations in H-Ras, N-Ras, and K-Ras varying by tumor type. Understanding these mutations and their downstream effects is crucial for developing targeted cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workload for infection prevention and control teams in preventing nosocomial tuberculosis: an underestimated burden.

The Journal of hospital infection·2022
Same author

Ancient DNA, lipid biomarkers and palaeoecological evidence reveals construction and life on early medieval lake settlements.

Scientific reports·2021
Same author

Family-focused practice within a recovery framework: practitioners' qualitative perspectives.

BMC health services research·2017
Same author

In-hospital mortality risk of intertrochanteric hip fractures: a comprehensive review of the US Medicare database from 2005 to 2010.

Musculoskeletal surgery·2017
Same author

ABO-Incompatible Kidney Transplants: Twice as Expensive, Half as Good.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

A Cost-Benefit Analysis of Government Compensation of Kidney Donors.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Ras proteins (including H-Ras, N-Ras, and K-Ras) are directly implicated in the pathogenesis of human cancers.
  • The varying frequencies of Ras mutations across different tumor types remain poorly understood.
  • Other Ras superfamily members and downstream pathways (e.g., B-Raf, PTEN, PI 3' kinase) also contribute to oncogenesis.

Purpose of the Study:

  • To explore the role of Ras proteins and their associated pathways in human cancer.
  • To investigate the complex interactions and mutational patterns within the Ras signaling network.
  • To assess the therapeutic potential and validation status of targets within the Ras pathway.

Main Methods:

  • Analysis of mutation frequencies of H-Ras, N-Ras, and K-Ras in various cancer types.

Related Experiment Videos

  • Examination of mutations in downstream effectors such as B-Raf, PTEN, and PI 3' kinase.
  • Review of drug development status for inhibitors targeting the Ras pathway, including Sorafenib.

    • Main Results:

    • Mutations in Ras proteins are a direct cause of human cancers.
    • Mutational patterns in Ras and its effectors can be mutually exclusive or coexistent, indicating complex pathway regulation.
    • Drugs targeting the Ras pathway, like Sorafenib, are in clinical development, with some approved for specific indications.

    Conclusions:

    • Ras pathway mutations are critical in cancer development and progression.
    • The intricate interplay between Ras and its effectors presents challenges and opportunities for targeted therapy.
    • Despite progress, the therapeutic validation of Ras pathway targets requires further investigation.